Le Lézard
Classified in: Business, Covid-19 virus
Subjects: ECO, FOR, CFG

Statement by the Deputy Prime Minister on the entry-into-force of the new NAFTA


OTTAWA, ON, June 30, 2020 /CNW/ - The Deputy Prime Minister, Chrystia Freeland, today issued the following statement on the entry-into-force of the new NAFTA:

"On behalf of the Government of Canada, I welcome the entry-into-force of the new NAFTA on July 1. This agreement, the result of extensive negotiations over the past three and a half years, is an essential pillar in preserving free and fair trade in North America.

"The new NAFTA protects jobs and prosperity for workers in all three NAFTA countries. It is good for Canada and good for Canadian workers. It will help ensure that North America emerges stronger from the COVID-19 pandemic.

"To Canadians from across the country and all sectors of the economy and society who provided valuable input in the negotiations: thank you. This accomplishment belongs to all Canadians.

"Our government is committed to working with our NAFTA partners to ensure this new agreement becomes a success for all three countries."

Quick Facts

 

SOURCE Deputy Prime Minister's Office


These press releases may also interest you

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 21:00
The economic turmoil triggered by the COVID-19 pandemic has led to a sharp decrease in the number of self-employed individuals in the United States, with a 22% reduction...

at 19:30
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIO® (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...

at 18:51
Banco Latinoamericano de Comercio Exterior, S.A. , a Panama-based multinational bank originally established by the central banks of 23 Latin-American and Caribbean countries to promote foreign trade and economic integration in the Region, announced...



News published on and distributed by: